| 000 | 01402 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515054235.0 | ||
| 264 | 0 | _c20070212 | |
| 008 | 200702s 0 0 ger d | ||
| 022 | _a1661-8157 | ||
| 024 | 7 |
_a10.1024/1661-8157.96.1.3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuter-Meyer, E | |
| 245 | 0 | 0 |
_a[Common variable immunodeficiency (CVID) -- variable immunodeficiency syndrome]. _h[electronic resource] |
| 260 |
_bPraxis _cJan 2007 |
||
| 300 |
_a3-10; quiz 11-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCommon Variable Immunodeficiency _xcomplications |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xblood |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 | _aLife Expectancy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNigg, C | |
| 700 | 1 | _aNaumann, U Kolyvanos | |
| 700 | 1 | _aKäser, L | |
| 700 | 1 | _aVetter, W | |
| 773 | 0 |
_tPraxis _gvol. 96 _gno. 1-2 _gp. 3-10; quiz 11-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1024/1661-8157.96.1.3 _zAvailable from publisher's website |
| 999 |
_c16818478 _d16818478 |
||